Patient Guide: Efficacy, Safety and Tolerability of KLU156 in Adults and Children ≥ 5 kg Body Weight With Uncomplicated P. Falciparum Malaria

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 34 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05842954
Status: ACTIVE_NOT_RECRUITING
Condition: Uncomplicated Plasmodium Falciparum Malaria
Phase: PHASE3

Where You Can Participate

This study is available at 34 locations across the country.

Top locations include:
  • • Banfora,
  • • Bobo Dioulasso,
  • • Nanoro,
  • • And 31 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Efficacy, Safety and Tolerability of KLU156 in Adults and Children ≥ 5 kg Body Weight With Uncomplicated P. Falciparum Malaria - Join Clinical Trial NCTNCT05842954

How to Join This Clinical Trial - NCTNCT05842954

Learn how to participate in this PHASE3 trial studying an investigational therapy for Uncomplicated Plasmodium Falciparum Malaria. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Uncomplicated Plasmodium Falciparum Malaria. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Uncomplicated Plasmodium Falciparum Malaria
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05842954 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 34 locations. Find a study site near you:

Clinical Research Site

Banfora, - Burkina Faso

Status: Contact for availability

Clinical Research Site

Bobo Dioulasso, 01 - Burkina Faso

Status: Contact for availability

Clinical Research Site

Nanoro, BP 18 - Burkina Faso

Status: Contact for availability

Clinical Research Site

Ouagadougou, 11 BP 218 - Burkina Faso

Status: Contact for availability

Clinical Research Site

Sabou, 06 BP 10248 - Burkina Faso

Status: Contact for availability

Clinical Research Site

Commune De La Kenya Lubumbashi, Du Haut Katanga - Congo, The Democratic Republic of the

Status: Contact for availability

Clinical Research Site

Kimpese, Kongo Central - Congo, The Democratic Republic of the

Status: Contact for availability

Clinical Research Site

Kisantu, Kongo Central - Congo, The Democratic Republic of the

Status: Contact for availability

Clinical Research Site

Kenge, Kwango - Congo, The Democratic Republic of the

Status: Contact for availability

Clinical Research Site

Masi Manimba, Kwilu - Congo, The Democratic Republic of the

Status: Contact for availability

And 24 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Uncomplicated Plasmodium Falciparum Malaria:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships